These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


763 related items for PubMed ID: 17378918

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.
    Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ.
    Arch Neurol; 2006 Jan; 63(1):49-54. PubMed ID: 16401736
    [Abstract] [Full Text] [Related]

  • 28. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
    Görtelmeyer R, Erbler H.
    Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
    [Abstract] [Full Text] [Related]

  • 29. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.
    Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, Swift RM, Addolorato G.
    Alcohol; 2008 Aug; 42(5):375-81. PubMed ID: 18486430
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
    Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR, Atomoxetine ADHD/SUD Study Group.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):145-54. PubMed ID: 18403134
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: three-month drinking outcomes.
    Brown RL, Saunders LA, Bobula JA, Mundt MP, Koch PE.
    Alcohol Clin Exp Res; 2007 Aug 01; 31(8):1372-9. PubMed ID: 17550366
    [Abstract] [Full Text] [Related]

  • 35. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT, Pejović V, Miller ML, Graham SM.
    Dement Geriatr Cogn Disord; 2009 Aug 01; 27(2):164-72. PubMed ID: 19194105
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R.
    Alzheimer Dis Assoc Disord; 2006 Aug 01; 20(1):23-9. PubMed ID: 16493232
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
    Ditzler K.
    Arzneimittelforschung; 1991 Aug 01; 41(8):773-80. PubMed ID: 1781796
    [Abstract] [Full Text] [Related]

  • 38. A prospective PMS study to validate the sensitivity for change of the D-scale in advanced stages of dementia using the NMDA-antagonist memantine.
    Rüther E, Glaser A, Bleich S, Degner D, Wiltfang J.
    Pharmacopsychiatry; 2000 May 01; 33(3):103-8. PubMed ID: 10855461
    [Abstract] [Full Text] [Related]

  • 39. Open-label pilot study of memantine in the treatment of compulsive buying.
    Grant JE, Odlaug BL, Mooney M, O'Brien R, Kim SW.
    Ann Clin Psychiatry; 2012 May 01; 24(2):119-26. PubMed ID: 22563566
    [Abstract] [Full Text] [Related]

  • 40. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
    Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y, Fijal BA, Ouyang H, Dharia S, Sundseth SS, Schuh KJ, Kinon BJ.
    Alcohol Clin Exp Res; 2014 Feb 01; 38(2):511-20. PubMed ID: 24010675
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.